Copyright
©The Author(s) 2025.
World J Meta-Anal. Mar 18, 2025; 13(1): 100523
Published online Mar 18, 2025. doi: 10.13105/wjma.v13.i1.100523
Published online Mar 18, 2025. doi: 10.13105/wjma.v13.i1.100523
Table 1 Description of the studies included in the integrative review, according to the type of treatment investigated
Ref. | Country | Type of study | Number of participants, gender and age | Objectives | Groups and treatments | Parameters evaluated | Main results |
Lactose-free diet | |||||||
Asik et al[15] | Türkiye | Case-control | 50 patients with HT (Female: 48; Male: 02). Average age: 47.9 ± 8.73 years | To evaluate the prevalence of lactose intolerance in patients with HT and the effects of lactose restriction on thyroid function in these patients | Groups: 1: Lactose intolerant (n = 48); 2: No lactose intolerance (n = 12); Time: 8 weeks | TSH, fT4, calcium, and parathormone (PTH) | The TSH levels decreased in patients with HT and lactose intolerance. Patients without lactose intolerance did not have significant changes in TSH levels. The other parameters did not change after lactose restriction |
Gluten-free diet | |||||||
Krysiak et al[16] | Poland | Case-control | 34 women with HT. Average age: Group A = 30 ± 5 years; Group B = 31 ± 6 years | To investigate whether a gluten-free diet affects thyroid function in women with HT | Group A: Gluten-free diet (n = 16); Group B: Gluten-containing diet (n = 18); Time: 6 months | Titers of TPOAb and TgAb; serum levels of TSH, fT3, fT4 and 25-hydroxyvitamin D | In group A, TPOAb and TgAb levels decreased and Vitamin D increased. TSH, fT3, and fT4 levels remained unchanged. In group B, the evaluated parameters remained unchanged |
Gluten-free diet for patients with CD and HT | |||||||
Virili et al[17] | Italy | Case report | 103 individuals with HT and/or CD (Female: 92; Male: 11); Age: Patients with HT: 41 (33-51); Patients with HT and CD: 39 (33-50) | To analyze the need to increase fT4 in CD patients adhering to a gluten-free diet | Patients with isolated HT: Gluten-containing diet; Patients with HT and CD: Gluten-free diet; Time: 15 months | TSH, TPOAb, weight and BMI | It was observed that there was a need to increase the fT4 dose by up to 50% in patients with HT and CD who were non-adherent to a gluten-free diet. However, this can be reversed if a gluten-free diet is implemented. Normal thyroid levels were observed after the gluten-free diet, but the same result was obtained after increasing the fT4 dose in patients who were non-adherent to the diet |
Gluten-free diet associated with healthy lifestyle and nutritional follow-up | |||||||
Pobłocki et al[18] | Poland | Case-control | 62 women with HT. Average age: 38.86 ± 4.28 years | To evaluate whether the use of a gluten-free diet is effective in patients with HT | Group selection: Gluten-free diet (n = 31); Control group: Average Pole’s diet (n = 31); Time: 12 months | Serum levels of TSH, fT3, fT4, and Titers of TPOAb and TgAb, weight and BMI | There was a reduction in TSH in the study group and an increase in fT4 levels, the other parameters did not change in either group |
Gluten-free diet with selenium supplementation | |||||||
Velija et al[19] | United Kingdom | Case-control | 98 women with HT. Average age: 39.60 ± 7.36 years | To validate the positive effect of HT patients adhering to a gluten-free diet and selenium supplementation on the recovery of thyroid function | Group A: Receiving 200 μg selenium in the form of L-selenomethionine orally and gluten-free diet (n = 50); Group B: Receiving 200 μg selenium without any dietary treatment (n = 48); Time: 6 months | Titers of TPOAb and TgAb, and serum levels of TSH, fT3, fT4 | At the end of the study, euthyroidism was restored in 74% of group A participants, and in 58.3% of group B participants. TSH, TPOAb and TgAb levels were significantly reduced in both group after six months of treatment. Serum TPOAb titer in group A had a more significant decrease (by 49%) than those in group B (by 34%) |
Calorie reduction and food exclusion diet | |||||||
Ostrowska et al[20] | Poland | Case-control | 100 women with HT and obesity. Average age: Group A = 42.7 ± 10.51 years; Group B = 41.02 ± 11.96 years | To evaluate the influence of calorie reduction diets, with and without food exclusion, on thyroid parameters in women | Group A: Calorie reduction and food exclusion diet (n = 50); Group B: Calorie reduction diet without excluding foods (n = 50). Average reduction of 1000 kcal/day in both diets. Time: 6 months | Titers of TPOab and TgAb, and serum levels of TSH, fT3, fT4, weight and BMI | In both groups, loss of body mass and decrease in BMI were observed, in group A this loss was greater. Both groups obtained decreases in the parameters of TSH, TPOAb, TgAb, and an increase in fT3 and fT4 in group A |
Paleo diet with exclusion of gluten, grains, dairy and micronutrient supplementation | |||||||
Avard and Grant[21] | Australia | Case report | Woman with HT, 23 years | To validate whether an approach to modulating the intestinal microbiota and reducing inflammation can be used as methods to regulate intestinal permeability and favor the course of HT treatment | Paleo diet with exclusion of gluten, grains, dairy, low-protein with micronutrient supplementation (vitamin C, D, B1, B4, B5, B6, B12, zinc, selenium, iron a N-Acetyl cysteine) and probiotics. Time: 15 months | Serum levels of TSH, fT4, zinc, ferritin, Vitamin D and B12, Titers of TPOAb and TgAb | Reduction in TSH and TgAb levels and significant improvement in the symptoms that most affected the patient (daytime naps, exhaustion, stress and mood swings, excessive fatigue, hair loss, nighttime insomnia), only intestinal transit, which despite improving, remained unstable |
Autoimmune diet and lifestyle changes | |||||||
Abbott et al[22] | United States | Pilot study | 16 women with HT. Average age: 35.6 ± 5.7 years | To determine the efficacy of a multi-disciplinary diet and lifestyle intervention for improving the quality of life,clinical symptom burden, and thyroid function in a population of middle-aged women with HT | Online health coaching program focused on the implementation of a phased elimination diet known as the Autoimmune Protocol. Time: 10 weeks | Complete metabolic profile, serum levels of TSH fT3, fT4, titers of TPOAb, TgAb, CRP, symptom and quality of life questionnaires | No changes in TSH, fT3, fT4, TPOAb, TgAb. Improvement in health and quality of life. Clinical symptoms with significant decrease. In the CRP test there was a decrease of 29% |
Autoimmune and hypocaloric Paleo diet (1200 kcal) | |||||||
Al-Bayyari[23] | Jordan | Case report | Woman with HT, 49 years | To observe the effect of a modified paleo immune diet on anthropometry, body composition, insulin, lipid profile and thyroid function of the patient analyzed | Modified autoimmune paleo low-calorie diet (1200 kcal). Time: 6 months | Anthropometric measurements, body composition, fasting blood glucose and insulin, serum levels of HDL-c, LDL-c, triglycerides, fT3, fT4, TSH, and titers of TPOAb | Reduction in anthropometric measurements, body composition, triglycerides, LDL, TSH, TPOAb, and insulin. There were no changes in fT3, fT4. There was an increase in HDL-c |
- Citation: Santos CS, Carteri RB, Coghetto C, Czermainski J, Rosa CB. Nutritional interventions in the treatment of Hashimoto’s disease: A systematic review. World J Meta-Anal 2025; 13(1): 100523
- URL: https://www.wjgnet.com/2308-3840/full/v13/i1/100523.htm
- DOI: https://dx.doi.org/10.13105/wjma.v13.i1.100523